← Leaderboards
Robert Michael Tuttle
Sloan-Kettering Inst Can Research
$1,173,231
Attributed
$3,519,694
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $723.4K · FY2016–20$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,519,694 · 1
By mechanism
R01$3,519,694 · 1
Top collaborators
- John L Humm5 shared
- Steven M Larson5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- James A Fagin$27,970,638
- Richard N Kolesnick$17,601,323
- Thomas Reiner$4,804,085
- Alan L. Ho$4,883,159
- Nancy Y Lee$8,718,881
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionGamma RaysAblationAlternative TherapiesAvidityBaseBiologicalBraf GeneCancer PatientClinicClinical PracticeClinical TrialsDiagnosticDiscipline Of Nuclear MedicineDisease ManagementDistant MetastasisDoseDosimetryDysmyelopoietic SyndromesDysplasiaEndocrinologistErbb3 GeneEvaluationGenes
Grant awards (5)
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$723,362
R01 · FY2020 · CA
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$706,749
R01 · FY2019 · CA
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$695,342
R01 · FY2018 · CA
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$695,342
R01 · FY2017 · CA
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer$698,899
R01 · FY2016 · CA